Sylvia Mcbrinn - Jun 16, 2022 Form 4 Insider Report for BioAtla, Inc. (BCAB)

Role
Director
Signature
/s/ Christian Vasquez, as Attorney-in-Fact for Sylvia McBrinn
Stock symbol
BCAB
Transactions as of
Jun 16, 2022
Transactions value $
$0
Form type
4
Date filed
6/17/2022, 07:58 PM
Previous filing
Jun 17, 2022
Next filing
Sep 20, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BCAB Stock Option (right to buy) Award $0 +20K $0.00 20K Jun 16, 2022 Common Stock 20K $2.48 Direct F1
transaction BCAB Stock Option (right to buy) Award $0 +5.7K +30.1% $0.00 24.6K Jun 16, 2022 Common Stock 5.7K $39.64 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 100% of the total number of shares subject to the option shall vest and become exercisable on the earlier of (a) June 16, 2023 or (b) the next annual meeting of stockholders, subject to the reporting person continuing to provide services through the vesting date.
F2 On June 17, 2021, the reporting person filed a Form 4 in respect of an option covering 24,615 shares. Such option was granted on June 15, 2021 pursuant to the Company's non-employee director compensation policy. The Company subsequently determined that 5,695 of the shares comprising such award were null and void upon grant as a result of the $750,000 annual limit for non-employee director compensation under its 2020 Equity Incentive Plan. As a result on June 16, 2022, the Board of the Company granted a make-whole option covering 5,695 shares to the reporting person. Such make-whole option has the same vesting, expiration and other terms as the option granted on June 15, 2021.
F3 1/3 of the total number of shares subject to the make-whole option were fully vested and exercisable on the date of the grant and 1/36th of the total number of shares subject to the make-whole option shall vest monthly commencing on July 15, 2022, subject to the reporting person continuing to provide services to the Company throughout the vesting date.